News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Sumanta K. Pal: Examining docetaxel, apalutamide and radiotherapy in PSA recurrent prostate cancer
Photo taken from Tian Zhang/Twitter
Jul 10, 2024, 07:36

Sumanta K. Pal: Examining docetaxel, apalutamide and radiotherapy in PSA recurrent prostate cancer

Sumanta K. Pal shared on X:

“Congrats Tian Zhang and team on this terrific paper in European Urology Oncology examining docetaxel, apalutamide and radiotherapy in PSA recurrent prostate cancer!”

Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial

Authors: Tian Zhang, Lauren Howard, Bridget F. Koontz, Scott T. Tagawa, Himanshu Nagar, Rhonda L. Bitting, Bart       A. Frizzell, Luke Nordquist, Julia Rasmussen, Colleen Riggan, Marco Reyes, Catrin Davies, Steven R. Gray, Carly R. Newman, Escarleth Fernandez, Sundhar Ramalingam, Michael R. Harrison, Daniel J. George, Yuan Wu, Andrew J. Armstrong

Sumanta K. Pal

Source: Sumanta K. Pal/X

Andrew J. Armstrong Bart A. Frizzell Bridget F. Koontz cancer Carly R. Newman Catrin Davies Colleen Riggan Daniel J. George Escarleth Fernandez European Urology Oncology Himanshu Nagar Julia Rasmussen Lauren Howard Luke Nordquist Marco Reyes Michael R. Harrison OncoDaily Oncology prostate cancer radiotherapy Rhonda L. Bitting Scott T. Tagawa Steven R. Gray Sumanta K. Pal Sundhar Ramalingam Tian Zhang Yuan Wu
Special Coverage
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe